/**/ document.writeln("\n\n\n\n\n \n\n\n\n\n \n \n \n\n
\n\n \n
\n \n \n \n \n
 Recent News for Spectrum Pharmaceuticals Inc.\n \n\n\n\n\n
Nov 23 7:40 AM EST
\n\n\n\n
\n \n
\n \n \n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n Nov 23, 2009 7:00 AM EST
\n\n \n Spectrum Pharmaceuticals and Handok Pharmaceuticals Announce Collaboration Agreement for Apaziquone in South Korea - Business Wire\n \n \n
\n\n Nov 16, 2009 12:49 PM EST
\n\n \n Spectrum Pharmaceuticals Added to NASDAQ Biotechnology Index - Business Wire\n \n \n
\n\n Nov 13, 2009 8:02 PM EST
\n\n \n Semi-Annual Changes to the NASDAQ Biotechnology Index - GlobeNewswire\n \n \n
\n\n Nov 12, 2009 7:00 AM EST
\n\n \n Spectrum Pharmaceuticals Announces Third Quarter 2009 Corporate Update; ZEVALIN(R) Sales up 80% over Third Quarter 2008 - Business Wire\n \n \n
\n\n Nov 10, 2009 9:00 AM EST
\n\n \n Spectrum Pharmaceuticals and Nippon Kayaku Enter Collaboration Agreement for Apaziquone in Asian Territories - Business Wire\n \n \n
\n\n Nov 06, 2009 7:00 AM EST
\n\n \n Spectrum Pharmaceuticals Announces Date for Third Quarter 2009 Corporate Update and Pipeline Review Conference Call - Business Wire\n \n \n
\n\n Nov 03, 2009 7:00 AM EST
\n\n \n ZEVALIN(R) Receives Positive Reimbursement Ruling Using Average Sales Price (ASP) Methodology - Business Wire\n \n \n
\n
\n\n");